Latest
News
2024
-
February 28, 2024
Read Article
Chitogenx announces executive leadership changes -
January 3, 2024
Read Article
Chitogenx reports third quarter 2024 results
- 2023
-
November 9, 2023
Read Article
Chitogenx demonstrates ortho-r efficacy and osteoarthritis protection in large animal meniscal repair study -
November 7, 2023
Read Article
Chitogenx launches burn and skin repair development program -
September 29, 2023
Read Article
Chitogenx reports second quarter 2024 results -
September 28, 2023
Read Article
Chitogenx receives notice of allowance for key patent in united states and canada -
September 26, 2023
Read Article
Chitogenx concludes enrolment for its u.s. phase i/ii rotator cuff tear repair clinical trial -
August 2, 2023
Read Article
Chitogenx announces voting results of its annual general meeting of shareholders -
June 30, 2023
Read Article
Chitogenx reports first quarter 2024 results -
June 15, 2023
Read Article
Chitogenx retains bruder consulting & venture group to broaden and accelerate ongoing strategic development partnership discussions -
June 5, 2023
Read Article
Chitogenx closes $288,000 second tranche of non-brokered private placement offering -
May 31, 2023
Read Article
Chitogenx reports 2023 fiscal year-end results -
May 5, 2023
Read Article
Chitogenx closes $3.9 million non-brokered private placement offering -
May 1, 2023
Read Article
Chitogenx amends terms of previously announced non-brokered private placement -
April 14, 2023
Read Article
Chitogenx announces change of auditors -
April 4, 2023
Read Article
Chitogenx announces new $2.5 million non-brokered private placement offering and balance sheet restructuring -
February 16, 2023
Read Article
Chitogenx announces $3.5 million grant to advance ortho-r commercial development -
February 14, 2023
Read Article
Chitogenx demonstrates ortho-r residency properties in meniscus study -
February 9, 2023
Read Article
Chitogenx announces up to $4.35 million private placement pursuant to the listed issuer exemption
-
- 2022
-
December 29, 2022
Read Article
Chitogenx reports its third quarter 2023 results -
November 9, 2022
Read Article
Chitogenx successfully completes initial portion of its u.s. phase i/ii rotator cuff repair clinical trial -
October 19, 2022
Read Article
Chitogenx signs memorandum of understanding with california medical innovations institute (calmi2) -
October 13, 2022
Read Article
Chitogenx launches second orthopedic development program in meniscus repair -
October 5, 2022
Read Article
Chitogenx to pursue sales of medical grade chitosan as new near-term revenue initiative -
September 29, 2022
Read Article
Chitogenx reports its second quarter 2023 results -
September 7, 2022
Read Article
Ortho regenerative technologies announces corporate name change to chitogenx -
July 27, 2022
Read Article
Ortho regenerative technologies announces enrollment of first patient in its u.s. phase i/ii rotator cuff tear repair clinical trial -
July 22, 2022
Read Article
Ortho regenerative technologies announces voting results of its annual general and special meeting of shareholders -
June 24, 2022
Read Article
Ortho regenerative technologies reports its first quarter 2023 results -
June 13, 2022
Read Article
Ortho regenerative technologies initiates patients recruitment for its u.s. phase i/ii rotator cuff tear repair clinical trial -
May 26, 2022
Read Article
Ortho regenerative technologies receives $500,000 axelys grant to advance ortho-m development for meniscus repair -
May 20, 2022
Read Article
Ortho regenerative technologies reports its fourth quarter and 2022 year-end results -
May 4, 2022
Read Article
Ortho regenerative technologies receives key u.s. composition and method patent for ortho-r soft tissue repair platform -
April 6, 2022
Read Article
Ortho regenerative technologies closes oversubscribed non-brokered private placement for $3.2 million -
March 24, 2022
Read Article
Ortho regenerative technologies to participate in the 2022 virtual growth conference presented by maxim group llc and hosted by m-vest -
March 21, 2022
Read Article
Ortho regenerative technologies amends the terms of its $3 million non-brokered private placement of units -
March 15, 2022
Read Article
Ortho regenerative technologies announces executive leadership changes -
February 11, 2022
Read Article
Ortho regenerative technologies announces $3 million non-brokered private placement of units -
February 7, 2022
Read Article
Ortho regenerative technologies enters into a material transfer agreement with a global strategic medical company for its ortho-r rotator cuff tear repair phase i/ii u.s. clinical trial
-
- 2021
-
December 21, 2021
Read Article
Ortho regenerative technologies reports its third quarter 2022 results -
December 13, 2021
Read Article
Ortho regenerative technologies closes non-brokered $1.05 million private placement -
December 13, 2021
Read Article
Ortho regenerative technologies announces u.s. ind clinical hold lifted by the fda & clearance to proceed with u.s. clinical trial -
November 12, 2021
Read Article
Ortho regenerative technologies announces filing of response to type a meeting with fda and non-brokered $1.5 million private placement -
October 6, 2021
Read Article
Ortho regenerative technologies announces successful type a meeting with u.s. fda on cmc elements for which more information was required to clear ind clinical hold -
September 30, 2021
Read Article
Ortho regenerative technologies reports its second quarter 2022 results -
August 20, 2021
Read Article
Ortho regenerative technologies announces extension of fda clinical hold of ortho-r investigational new drug application -
July 21, 2021
Read Article
Ortho regenerative technologies announces voting results of its annual general and special meeting of shareholders -
July 20, 2021
Read Article
Ortho regenerative technologies submits formal response to u.s. fda clinical hold -
July 19, 2021
Read Article
Ortho regenerative technologies announces amendments and extension of unsecured convertible debentures and warrants -
June 29, 2021
Read Article
Ortho regenerative technologies reports its first quarter 2022 results -
June 15, 2021
Read Article
Ortho regenerative technologies appoints two new members to its board of directors -
June 4, 2021
Read Article
Ortho regenerative technologies receives clinical hold letter from the u.s. fda -
June 1, 2021
Read Article
Ortho regenerative technologies reports its fourth quarter and 2021 year-end results -
April 6, 2021
Read Article
Ortho regenerative technologies announces submission of investigational new drug application for ortho-r -
March 31, 2021
Read Article
Ortho regenerative technologies secures dtc eligibility for the trading of its shares on the us otcqb market -
March 2, 2021
Read Article
Ortho regenerative technologies well-positioned for next phase of development -
February 24, 2021
Read Article
Ortho regenerative technologies adds patrick o’donnell to board of directors -
February 10, 2021
Read Article
Ortho regenerative technologies launches agoracom platform for online investors outreach -
February 4, 2021
Read Article
Ortho regenerative technologies retains westwicke icr as investor relations advisors for the u.s. -
January 5, 2021
Read Article
Ortho regenerative technologies enters into global license with hanuman pelican, inc.
-
- 2020
-
December 18, 2020
Read Article
Ortho regenerative technologies reports its third quarter 2021 results -
December 3, 2020
Read Article
Ortho regenerative technologies completes non-brokered $3.0 million private placement -
October 28, 2020
Read Article
Ortho regenerative technologies begins trading on the otcqb u.s. market -
October 19, 2020
Read Article
Ortho regenerative technologies announces the nomination of its new vice-president clinical and medical affairs -
September 25, 2020
Read Article
Ortho regenerative technologies reports its second quarter 2021 results -
September 2, 2020
Read Article
Ortho regenerative technologies completes additional private placement -
August 31, 2020
Read Article
Ortho regenerative technologies announces non-brokered private placement of units -
August 24, 2020
Read Article
Ortho regenerative technologies closes non-brokered $2.5 million private placement -
August 6, 2020
Read Article
Ortho regenerative technologies announces fda regulatory designation and jurisdictional assignment for ortho-r -
July 24, 2020
Read Article
Ortho regenerative technologies announces non-brokered private placement of units -
July 23, 2020
Read Article
Ortho regenerative technologies releases new positive histology results from pivotal preclinical glp rotator cuff tear repair efficacy study in large-animal model -
June 30, 2020
Read Article
Ortho regenerative technologies reports its first quarter 2021 results -
June 22, 2020
Read Article
Ortho regenerative technologies announces the nomination of a new independent chairman of the board -
May 29, 2020
Read Article
Ortho regenerative technologies reports its fourth quarter and 2020 year-end results -
May 20, 2020
Read Article
Ortho regenerative technologies enters into licensing agreement to expand the scope of its technological platform applications -
April 22, 2020
Read Article
Ortho regenerative technologies advances ortho-r regulatory and clinical projects with $1.1 million private placement -
March 12, 2020
Read Article
Ortho regenerative technologies announces positive results from pivotal preclinical study in rotator cuff tear repair
-
- 2019
-
December 31, 2019
Read Article
Ortho regenerative technologies reports its third quarter 2020 financial results -
December 30, 2019
Read Article
Ortho regenerative technologies announces non-brokered private placement of convertible debenture units -
December 12, 2019
Read Article
Ortho rti announces extension of certain early warrants -
October 15, 2019
Read Article
Ortho rti announces extension of certain early warrants -
October 9, 2019
Read Article
Ortho regenerative technologies closes $1.6 million private placement -
October 1, 2019
Read Article
Ortho regenerative technologies reports its second quarter 2020 financial results -
September 12, 2019
Read Article
Ortho regenerative technologies selects us based specialized cro, mcra llc, for its upcoming phase i/ii rotator cuff human trial -
September 10, 2019
Read Article
Ortho regenerative technologies to present at the fall investor summit on september 17, 2019 in new york city -
August 28, 2019
Read Article
Ortho regenerative technologies announces collaborative agreement with leading global orthopaedic company -
August 14, 2019
Read Article
Ortho regenerative technologies provides business update on its ortho-r rotator cuff program -
August 5, 2019
Read Article
Ortho rti announces extension of certain early warrants -
July 3, 2019
Read Article
Ortho regenerative technologies reports its first quarter 2020 financial results and announces non-brokered private placement -
June 20, 2019
Read Article
Ortho regenerative technologies appoints pierre laurin to its board of directors -
June 17, 2019
Read Article
Ortho regenerative technologies announces changes in executive leadership -
February 27, 2019
Read Article
Ortho rti confirms timeline to initiate human clinical program after meeting with the fda -
February 11, 2019
Read Article
Ortho rti announces initiation of pivotal study on ortho-r for rotator cuff repair -
February 4, 2019
Read Article
Ortho rti announces more prestigious scientific validation
-
- 2018
-
December 13, 2018
Read Article
Ortho rti's data selected for podium presentation at international conference. -
October 10, 2018
Read Article
Evidence on the safety and efficacy of ortho-r in a large animal model presented at 2018 sicot world congress. -
September 19, 2018
Read Article
Ortho regenerative technologies inc. appoints accomplished life science executive, luc mainville, as cfo. -
September 6, 2018
Read Article
Ortho rti signs agreement with a leading cmo for the manufacture of cgmp finished dosage form ortho-r in preparation for planned first-in-human study. -
August 31, 2018
Read Article
Ortho regenerative technologies inc. announces cfo change -
July 31, 2018
Read Article
Ortho rti announces extension of certain early warrants -
July 19, 2018
Read Article
Ortho rti announces closing of second tranche of non-brokered private placement -
June 13, 2018
Read Article
Ortho rti press release histopathology -
May 31, 2018
Read Article
Ortho rti announces the issuance of 3,610,000 shares pursuant to its non-brokered private placement -
May 25, 2018
Read Article
Ortho rti announces non-brokered private placement -
May 23, 2018
Read Article
Ortho rti receives notice of allowance for second european patent protecting ortho-r technology -
April 2, 2018
Read Article
Ortho rti announces compelling data from ortho-r pilot study in rotator cuff repair -
March 8, 2018
Read Article
Ortho rti receives notice of allowance for european patent protecting ortho-r technology -
January 8, 2018
Read Article
Ortho rti announces changes to its board of directors
-
- Older
-
October 18, 2016
Read Article
Ortho announces changes in executive leadership -
August 26, 2016
Read Article
Ortho regenerative technologies inc. announces receiving key patent -
August 3, 2016
Read Article
Ortho announces a private placement and closing of first tranche -
June 30, 2016
Read Article
Ortho grants of options and appoints new cfo -
May 20, 2016
Ortho regenerative technologies inc. presents advances in tissue repair in multiple podium presentations and posters at the 2016 world biomaterials congressMontreal, Canada, May 20th, 2016 - Ortho Regenerative Technologies Inc., a regenerative medical device company specializing in the repair of sports medicine injuries (the “Company”), announced today the presentation key technical advances in the mechanisms underlying the repair of soft tissue injuries through its proprietary biopolymer in 4 podium presentations and 2 poster presentations at the World Biomaterials Congress being held in Montreal, Canada from May 17-22, 2016.
-
December 9, 2015
Read Article
Manitex capital inc. affiliate, ortho regenerative technologies inc., announces the appointment of dr. ed margerrison as president and ceo
-